The first clinical trial of an Ebola vaccine has begun in the Democratic Republic of Congo (DRC), according to the head of the World Health Organization. The trial involves administering the Ervebo vaccine—which is already approved for the Zaire strain of Ebola—in a full-scale human trial to evaluate whether it provides cross-protection against the Bundibugyo strain.
This development comes as the DRC faces its worst-ever Ebola outbreak, which has surpassed 9,700 reported cases and resulted in more than 4,600 deaths.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Jamaica ObserverFocuses on the outbreak's severe scale, death toll, and operational challenges.
The HinduFocuses on the specific vaccine used and testing cross-protection against another strain.
Newz